Our pipeline addresses distinct hallmarks of the aging process by targeting well characterized proteins strongly implicated in age-related disease. We are developing a comprehensive gene therapy pipeline to correct:
- Defective cell division
- Muscle atrophy
GENE THERAPY
BV - TA829:
Dual Body Gene Therapy For Whole Body Age Reversal.
BV - FA829
Myostatin Inhibitor For Sarcopenia (Muscle Degeneration) And Atherosclerosis
BV - A829
Telomerase Gene Therapy Targeting Alzheimer's Disease
BV - T829
Telomerase Gene Therapy For Skin Regeneration